Note:This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Summary of Consolidated Financial Results for the Year Ended March 31, 2025
[Under Japanese GAAP]
May 9, 2025
Company name: SHIMA SEIKI MFG.,LTD. Listing: Tokyo Stock Exchange Securities code: 6222
URL: https://www.shimaseiki.co.jp/
Representative: Mitsuhiro Shima President and Representative Director
Inquiries: Shosaku Kitagawa Director, Managing Executive Officer General Manager of the
Corporate Planning Division
Telephone: +81-73-471-0511
Scheduled date of annual general meeting of shareholders: June 26, 2025 Scheduled date to commence dividend payments: June 27, 2025 Scheduled date to file annual securities report: June 27, 2025
Preparation of supplementary material on financial results: Yes Holding of financial results briefing: Yes
(Yen amounts are rounded down to millions, unless otherwise noted.)
-
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (April 1, 2024 to March 31, 2025)
-
Consolidated Operating Results (Percentages indicate year-on-year changes.)
Net sales
Operating profit
Ordinary profit
Profit attributable to owners of parent
Fiscal year ended
March 31, 2025
March 31, 2024
Millions of yen
32,520
35,910
%
(9.4)
(5.2)
Millions of yen
(11,914)
430
%
-
-
Millions of yen
(11,481)
1,018
%
-
-
Millions of yen
(14,275)
1,030
%
-
-
(Note) Comprehensive income:
Fiscal year ended March 31, 2025:
¥
(13,844) million
[
-%]
Fiscal year ended March 31, 2024:
¥
6,161 million
[
-%]
Basic earnings per share
Diluted earnings per share
Rate of return on equity
Ordinary profit to total assets ratio
Operating profit to net sales ratio
Fiscal year ended
Yen
Yen
%
%
%
March 31, 2025
(413.58)
-
(16.8)
(11.1)
(36.6)
March 31, 2024
29.85
29.84
1.2
1.0
1.2
(Reference) Equity in earnings (losses) of affiliated companies:
Fiscal year ended March 31, 2025:
¥
- million
(2) Consolidated Financial Position
Fiscal year ended March 31, 2024:
¥
- million
Total assets
Net assets
Capital adequacy ratio
Net assets per share
As of
March 31, 2025
March 31, 2024
Millions of yen
99,405
107,804
Millions of yen
77,740
91,926
%
78.2
85.2
Yen
2,251.04
2,662.21
(3) Consolidated Cash Flows(Reference) Equity: As of March 31, 2025:
¥
77,701 million
As of March 31, 2024:
¥
91,889 million
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at the end of period
Fiscal year ended March 31, 2025
March 31, 2024
Millions of yen
(4,461)
(4,120)
Millions of yen
(3,222)
(167)
Millions of yen
5,376
348
Millions of yen
10,363
12,809
-
Consolidated Operating Results (Percentages indicate year-on-year changes.)
-
Dividends
Annual dividends
Total dividends
Payout ratio (consolidated)
Dividends to net assets
(consolidated)
1st quarter-end
2nd quarter-end
3rd quarter-end
Year-end
Total
Fiscal year ended March 31, 2024
March 31, 2025
Yen
-
-
Yen
5.00
5.00
Yen
-
-
Yen
5.00
5.00
Yen
10.00
10.00
Millions of yen
345
345
%
33.5
(2.4)
%
0.4
0.4
Fiscal year ending March 31, 2026
(Forecast)
-
10.00
-
10.00
20.00
34.5
- Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2026 (April 1, 2025 to March 31, 2026)
(Percentages indicate year-on-year changes.)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Full year | Millions of yen 44,500 | % 36.8 | Millions of yen 1,500 | % - | Millions of yen 2,300 | % - | Millions of yen 2,000 | % - | Yen 57.94 |
* Notes: | ||
(1) Significant changes in the scope of consolidation during the period: | None | |
Newly included: - (Company name: Excluded: - (Company name: | ) ) |
Changes in accounting policies, changes in accounting estimates, and restatement
Changes in accounting policies due to revisions to accounting standards and other regulations: Yes
Changes in accounting policies due to other reasons: None
Changes in accounting estimates: Yes
Restatement: None
Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares): March 31, 2025: 35,800,000 shares
March 31, 2024: 35,800,000 shares
Number of treasury shares at the end of the period:
March 31, 2025: 1,281,734 shares
March 31, 2024: 1,283,801 shares
Average number of shares outstanding during the period:
Fiscal Year ended March 31, 2025: 34,517,858 shares
Fiscal Year ended March 31, 2024: 34,515,970 shares
(Reference) Overview of Non-consolidated Financial Results 1. Non-consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (April 1, 2024 to March 31, 2025)-
Non-consolidated Operating Results (Percentages indicate year-on-year changes.)
Net sales
Operating profit
Ordinary profit
Net income
Fiscal year ended
March 31, 2025
March 31, 2024
Millions of yen
25,873
29,818
%
(13.2)
(2.3)
Millions of yen
(7,113)
(1,092)
%
-
-
Millions of yen
(7,595)
(786)
%
-
-
Millions of yen
(9,729)
(535)
%
-
-
Basic earnings per share
Diluted earnings per share
Fiscal year ended
Yen
Yen
March 31, 2025
(281.88)
-
March 31, 2024
(15.50)
-
- Non-consolidated Financial Position
Total assets | Net assets | Capital adequacy ratio | Net assets per share | |
As of March 31, 2025 March 31, 2024 | Millions of yen 88,135 92,372 | Millions of yen 59,212 68,524 | % 67.2 74.2 | Yen 1,715.01 1,984.83 |
(Reference) Equity: As of March 31, 2025: | ¥ | 59,199 million |
As of March 31, 2024: | ¥ | 68,508 million |
Financial results reports are exempt from audit conducted by certified public accountants or an audit corporation.
Proper use of earnings forecasts, and other special matters (Cautions concerning the use of earnings forecasts)
Forward-looking statements provided in this document, including earnings forecasts, are based on the information currently available to the Company and certain assumptions considered reasonable.Actual business and other results may differ materially from the forecasts depending on various factors.
Consolidated Financial Statements
Consolidated Balance Sheets
(Millions of yen)
As of March 31, 2024
As of March 31, 2025
Assets
Current assets
Cash and deposits
14,822
14,129
Notes receivable - trade
15,283
14,654
Accounts receivable - trade
30,218
20,687
Merchandise and finished goods
13,526
12,428
Work in process
841
858
Raw materials and supplies
11,929
11,695
Other
1,532
1,364
Allowance for doubtful accounts
(4,135)
(1,612)
Total current assets
84,019
74,205
Non-current assets
Property, plant and equipment
Buildings and structures
27,928
27,739
Accumulated depreciation
(21,714)
(22,029)
Buildings and structures, net
6,213
5,709
Machinery, equipment and vehicles
6,044
5,951
Accumulated depreciation
(5,343)
(5,292)
Machinery, equipment and vehicles, net
701
658
Tools, furniture and fixtures
6,969
7,073
Accumulated depreciation
(6,110)
(6,162)
Tools, furniture and fixtures, net
858
911
Land
6,583
6,397
Leased assets
5,306
4,363
Accumulated depreciation
(4,681)
(3,907)
Leased assets, net
625
456
Construction in progress
82
51
Total property, plant and equipment
15,066
14,186
Intangible assets
152
78
Investments and other assets
Investment securities
5,493
6,115
Distressed receivables
2,411
11,335
Retirement benefit asset
1,202
1,225
Deferred tax assets
589
303
Other
1,261
1,425
Allowance for doubtful accounts
(2,392)
(9,468)
Total investments and other assets
8,566
10,936
Total non-current assets
23,785
25,200
Total assets
107,804
99,405
(Millions of yen)
As of March 31, 2024
As of March 31, 2025
Liabilities
Current liabilities
Accounts payable - trade
1,867
1,475
Electronically recorded obligations - operating
768
587
Short-term borrowings
2,500
8,800
Lease liabilities
673
511
Income taxes payable
242
206
Contract liabilities
1,734
1,536
Provision for bonuses
1,328
1,135
Provision for product warranties
-
292
Provision for loss on guarantees
80
38
Other
2,639
3,047
Total current liabilities
11,836
17,632
Non-current liabilities
Long-term accounts payable - other
53
44
Lease liabilities
836
670
Deferred tax liabilities
865
1,081
Deferred tax liabilities for land revaluation
17
18
Retirement benefit liability
1,997
2,016
Other
269
201
Total non-current liabilities
4,040
4,032
Total liabilities
15,877
21,665
Net assets
Shareholders' equity
Share capital
14,859
14,859
Capital surplus
23,422
23,420
Retained earnings
46,236
31,615
Treasury shares
(3,919)
(3,912)
Total shareholders' equity
80,599
65,983
Accumulated other comprehensive income
Valuation difference on available-for-sale securities
1,702
2,542
Revaluation reserve for land
33
33
Foreign currency translation adjustment
10,319
9,781
Remeasurements of defined benefit plans
(766)
(638)
Total accumulated other comprehensive income
11,290
11,718
Share acquisition rights
16
13
Non-controlling interests
21
25
Total net assets
91,926
77,740
Total liabilities and net assets
107,804
99,405
Consolidated Statements of Income and Comprehensive Income
Consolidated Statements of Income
(Millions of yen)
For the fiscal year ended March 31, 2024
For the fiscal year ended March 31, 2025
Net sales
35,910
32,520
Cost of sales
21,221
23,886
Gross profit
14,689
8,633
Selling, general and administrative expenses
14,258
20,548
Operating profit (loss)
430
(11,914)
Non-operating income
Interest income
696
694
Dividend income
162
214
Rental income
69
57
Other
351
167
Total non-operating income
1,279
1,133
Non-operating expenses
Interest expenses
51
48
Rental expenses on non-current assets
37
23
Foreign exchange losses
590
611
Provision of allowance for doubtful accounts
-
4
Other
12
13
Total non-operating expenses
691
701
Ordinary profit (loss)
1,018
(11,481)
Extraordinary income
Subsidy income
45
-
Gain on sale of investment securities
249
-
Total extraordinary income
295
-
Extraordinary losses
Loss on sale and retirement of non-current assets
-
51
Loss on valuation of investment securities
-
439
Impairment losses
-
1,495
Provision for product warranties
-
292
Total extraordinary losses
-
2,278
Profit (loss) before income taxes
1,313
(13,760)
Income taxes - current
191
232
Income taxes - deferred
90
280
Total income taxes
282
512
Profit (loss)
1,031
(14,272)
Profit attributable to non-controlling interests
0
2
Profit (loss) attributable to owners of parent
1,030
(14,275)
Consolidated Statements of Comprehensive Income
(Millions of yen)
For the fiscal year ended March 31, 2024
For the fiscal year ended March 31, 2025
Profit (loss)
1,031
(14,272)
Other comprehensive income
Valuation difference on available-for-sale securities
786
839
Revaluation reserve for land
-
(0)
Foreign currency translation adjustment
4,948
(538)
Remeasurements of defined benefit plans, net of tax
(604)
128
Total other comprehensive income
5,130
428
Comprehensive income
6,161
(13,844)
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
6,160 (13,847)
Comprehensive income attributable to non-controlling interests
0
2
Consolidated Statements of Changes in Equity
For the fiscal year ended March 31, 2024
(Millions of yen)
Shareholders' equity | |||||
Share capital | Capital surplus | Retained earnings | Treasury shares | Total shareholders' equity | |
Balance at beginning of period | 14,859 | 23,423 | 45,551 | (3,926) | 79,908 |
Changes during period | |||||
Dividends of surplus | (345) | (345) | |||
Profit (loss) attributable to owners of parent | 1,030 | 1,030 | |||
Purchase of treasury shares | (1) | (1) | |||
Disposal of treasury shares | (0) | 7 | 7 | ||
Net changes in items other than shareholders' equity | |||||
Total changes during period | - | (0) | 685 | 6 | 690 |
Balance at end of period | 14,859 | 23,422 | 46,236 | (3,919) | 80,599 |
Accumulated other comprehensive income | Share acquisition rights | Non-controlling interests | Total net assets | |||||
Valuation difference on available-for-sale securities | Revaluation reserve for land | Foreign currency translation adjustment | Remeasurements of defined benefit plans | Total accumulated other comprehensive income | ||||
Balance at beginning of period | 916 | 33 | 5,371 | (161) | 6,159 | 19 | 19 | 86,107 |
Changes during period | ||||||||
Dividends of surplus | (345) | |||||||
Profit (loss) attributable to owners of parent | 1,030 | |||||||
Purchase of treasury shares | (1) | |||||||
Disposal of treasury shares | 7 | |||||||
Net changes in items other than shareholders' equity | 786 | - | 4,948 | (604) | 5,130 | (3) | 2 | 5,128 |
Total changes during period | 786 | - | 4,948 | (604) | 5,130 | (3) | 2 | 5,819 |
Balance at end of period | 1,702 | 33 | 10,319 | (766) | 11,290 | 16 | 21 | 91,926 |
For the fiscal year ended March 31, 2025
(Millions of yen)
Shareholders' equity | |||||
Share capital | Capital surplus | Retained earnings | Treasury shares | Total shareholders' equity | |
Balance at beginning of period | 14,859 | 23,422 | 46,236 | (3,919) | 80,599 |
Changes during period | |||||
Dividends of surplus | (345) | (345) | |||
Profit (loss) attributable to owners of parent | (14,275) | (14,275) | |||
Purchase of treasury shares | (0) | (0) | |||
Disposal of treasury shares | (1) | 7 | 5 | ||
Net changes in items other than shareholders' equity | |||||
Total changes during period | - | (1) | (14,621) | 7 | (14,615) |
Balance at end of period | 14,859 | 23,420 | 31,615 | (3,912) | 65,983 |
Accumulated other comprehensive income | Share acquisition rights | Non-controlling interests | Total net assets | |||||
Valuation difference on available-for-sale securities | Revaluation reserve for land | Foreign currency translation adjustment | Remeasurements of defined benefit plans | Total accumulated other comprehensive income | ||||
Balance at beginning of period | 1,702 | 33 | 10,319 | (766) | 11,290 | 16 | 21 | 91,926 |
Changes during period | ||||||||
Dividends of surplus | (345) | |||||||
Profit (loss) attributable to owners of parent | (14,275) | |||||||
Purchase of treasury shares | (0) | |||||||
Disposal of treasury shares | 5 | |||||||
Net changes in items other than shareholders' equity | 839 | (0) | (538) | 128 | 428 | (3) | 4 | 429 |
Total changes during period | 839 | (0) | (538) | 128 | 428 | (3) | 4 | (14,186) |
Balance at end of period | 2,542 | 33 | 9,781 | (638) | 11,718 | 13 | 25 | 77,740 |
(4) Consolidated Statements of Cash Flows | ||
(Millions of yen) | ||
For the fiscal year | For the fiscal year | |
ended March 31, 2024 | ended March 31, 2025 | |
Cash flows from operating activities | ||
Profit (loss) before income taxes | 1,313 | (13,760) |
Depreciation | 995 | 1,189 |
Increase (decrease) in allowance for doubtful accounts | (924) | 4,660 |
Increase (decrease) in provision for product warranties | - | 292 |
Increase (decrease) in retirement benefit liability | 114 | 127 |
Interest and dividend income | (858) | (908) |
Interest expenses | 51 | 48 |
Foreign exchange losses (gains) | 840 | 60 |
Loss on sales of retirement of property, plant and equipment | - | 51 |
Loss (gain) on sale of investment securities | (249) | - |
Loss (gain) on valuation of investment securities | - | 439 |
Impairment losses | - | 1,495 |
Subsidy income | (45) | - |
Decrease (increase) in trade receivables | 1,070 | 895 |
Decrease (increase) in inventories | (5,547) | 1,135 |
Increase (decrease) in other current assets | (171) | 174 |
Increase (decrease) in trade payables | (963) | (546) |
Increase in other current liabilities | (266) | (227) |
Other, net | 238 | (235) |
Subtotal | (4,403) | (5,108) |
Interest and dividends received | 841 | 927 |
Interest paid | (51) | (53) |
Income taxes refund (paid) | (553) | (226) |
Subsidies received | 45 | - |
Net cash provided by (used in) operating activities | (4,120) | (4,461) |
Cash flows from investing activities | ||
Payments into time deposits | (2,572) | (5,908) |
Proceeds from withdrawal of time deposits | 2,754 | 3,922 |
Purchase of property, plant and equipment | (715) | (1,405) |
Proceeds from sale of property, plant and equipment | 62 | 324 |
Proceeds from sale of investment securities | 513 | - |
Other, net | (210) | (156) |
Net cash provided by (used in) investing activities | (167) | (3,222) |
(Millions of yen) | ||
For the fiscal year | For the fiscal year | |
ended March 31, 2024 | ended March 31, 2025 | |
Cash flows from financing activities | ||
Net increase (decrease) in short-term borrowings | 1,500 | 6,300 |
Repayments of finance lease liabilities | (804) | (577) |
Purchase of treasury shares | (1) | (0) |
Dividends paid | (345) | (344) |
Other, net | 0 | 0 |
Net cash provided by (used in) financing activities | 348 | 5,376 |
Effect of exchange rate change on cash and cash equivalents | 1,232 | (138) |
Net increase (decrease) in cash and cash equivalents | (2,707) | (2,446) |
Cash and cash equivalents at beginning of period | 15,517 | 12,809 |
Cash and cash equivalents at end of period | 12,809 | 10,363 |
